Evidence map›Paper›PMID 35594316›Full record

ArticlePLoS biology2022

A juxtamembrane basolateral targeting motif regulates signaling through a TGF-β pathway receptor in Drosophila.

Aidan J Peterson, Stephen J Murphy, Melinda G Mundt, MaryJane Shimell, Edward B Leof, Michael B O'Connor

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aidan J PetersonDepartment of Genetics, Cell Biology & Development and the Developmental Biology Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-6801-3364
Stephen J MurphyCenter for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Melinda G MundtDepartment of Genetics, Cell Biology & Development and the Developmental Biology Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-3317-6913
MaryJane ShimellDepartment of Genetics, Cell Biology & Development and the Developmental Biology Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0003-1378-6017
Edward B LeofThoracic Diseases Research Unit, Department of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Michael B O'ConnorDepartment of Genetics, Cell Biology & Development and the Developmental Biology Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-3067-5506
University of Minnesota · USMayo Clinic · US

Funding

Inter-organ signals regulating metabolism, physiology and developmental timingR35GM118029 · NIGMS · UNIVERSITY OF MINNESOTA · PI O'CONNOR, MICHAEL BRENDAN · 2016 to 2025
$3.8M
NIGMS NIH HHS R35 GM118029
6 · The paper itself

Abstract

In polarized epithelial cells, receptor-ligand interactions can be restricted by different spatial distributions of the 2 interacting components, giving rise to an underappreciated layer of regulatory complexity. We explored whether such regulation occurs in the Drosophila wing disc, an epithelial tissue featuring the TGF-β family member Decapentaplegic (Dpp) as a morphogen controlling growth and patterning. Dpp protein has been observed in an extracellular gradient within the columnar cell layer of the disc, but also uniformly in the disc lumen, leading to the question of how graded signaling is achieved in the face of 2 distinctly localized ligand pools. We find the Dpp Type II receptor Punt, but not the Type I receptor Tkv, is enriched at the basolateral membrane and depleted at the junctions and apical surface. Wit, a second Type II receptor, shows a markedly different behavior, with the protein detected on all membrane regions but enriched at the apical side. Mutational studies identified a short juxtamembrane sequence required for basolateral restriction of Punt in both wing discs and mammalian Madin-Darby canine kidney (MDCK) cells. This basolateral targeting (BLT) determinant can dominantly confer basolateral localization on an otherwise apical receptor. Rescue of punt mutants with transgenes altered in the targeting motif showed that flies expressing apicalized Punt due to the lack of a functional BLT displayed developmental defects, female sterility, and significant lethality. We also show that apicalized Punt does not produce an ectopic signal, indicating that the apical pool of Dpp is not a significant signaling source even when presented with Punt. Instead, we find that basolateral presentation of Punt is required for optimal signaling. Finally, we present evidence that the BLT acts through polarized sorting machinery that differs between types of epithelia. This suggests a code whereby each epithelial cell type may differentially traffic common receptors to enable distinctive responses to spatially localized pools of extracellular ligands.

Indexed as

DrosophilaDrosophila ProteinsTransforming Growth Factor betaAnimalsCell MembraneDogsFemaleLigandsMadin Darby Canine Kidney CellsProtein Serine-Threonine KinasesReceptors, Cell SurfaceReceptors, Transforming Growth Factor betadpp protein, DrosophilaDrosophila ProteinsLigandsProtein Serine-Threonine KinasesReceptors, Cell SurfaceReceptors, Transforming Growth Factor betatkv protein, DrosophilaTransforming Growth Factor betawit protein, Drosophila

Identifiers

PMID35594316
PMCPMC9162340
OpenAlexW4281261475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.